PUPetra Um-Bergström

Petra Um-Bergström

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Petra Um-Bergström has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Data Collection and Harmonization in Preterm Respiratory Research: Recommendations and Insights From PELICAN

    by H. L. Moore, S. Stanojevic, J. T. D. Gibbons, A. Bates, L. W. Doyle, N. Garland, N. Hemy, J. R. Hurst, S. Kotecha, E. Lombardi, et al.

    Introduction: Individuals born preterm (before 37 weeks’ gestation) have an increased risk of developing lung disease compared with those born at term. However, life‐long lung function trajectories and the factors influencing them remain insufficiently understood in this population, reflecting an unfortunate scarcity of data, substantial heterogeneity in findings, and variability across centers. The Prematurity's Effect on the Lungs in Children and Adults Network (PELICAN) was established in 2020 as a Clinical Research Collaboration of the European Respiratory Society, with a key aim to develop the first harmonized global repository of demographic, clinic and lung function data from existing datasets on individuals born preterm. Methods: Eligible datasets for inclusion were identified through three systematic literature reviews. A scientific steering committee was convened and organized into sub‐groups, which undertook a consensus‐based variable selection and data harmonization exercise. Data contributors uploaded data to a secure online portal, where further harmonization was applied. Results: As of June 2026, the PELICAN data repository includes 20 datasets representing 14 countries and 3,388 individuals born preterm. PELICAN collects 142 variables, of which 96 have been fully harmonized across all contributing datasets, and 42 partially harmonized. Four variables could not be harmonized. Conclusions: In this paper, we describe the PELICAN collaboration, outline key challenges and successes encountered during data harmonization, and report data availability to date. This work represents an important step towards understanding the respiratory consequences of preterm birth and could inform the development of a Core Outcome Set for future data collected in this area.

  • Open Access

    Comparison of airway mucin 5AC and 5B expression in preterm-born adults and asthma

    by Mervi Kreus, Petra Um-Bergström, Heta Merikallio, Elisa Lappi-Blanco, Ilkka Miinalainen, Nicole Y. Wagner, Eva Berggren-Broström, Erik Melén, Anders Lindén, Åsa M. Wheelock, et al.

    Background: As preterm birth is a risk factor for developing chronic lung disease later in life and has been associated with asthma-like symptoms, we hypothesised that preterm-born adults with and without a history of bronchopulmonary dysplasia (BPD) resemble patients with asthma with respect to altered mucin expression in the airways. Methods: Bronchial biopsies were retrieved from 39 adults born very-to-extremely preterm (of which 22 had a history of BPD), 18 adults with mild allergic asthma and 24 healthy controls. Mucin (MUC) 5AC and MUC5B protein expressions were determined by immunohistochemistry and immunoelectron microscopy. Additionally, the percentage of goblet cells was estimated. Results: MUC5AC expression and the percentage of goblet cells were lower in preterm-born adults than in asthma patients but did not markedly differ from those of healthy controls. In the preterm-born adults, MUC5AC expression correlated negatively with forced expiratory volume in 1 s to forced vital capacity ratio (FEV 1 /FVC) and positively with St George's Respiratory Questionnaire scores. Preterm-born adults with high MUC5AC expression had more bronchial hyperreactivity than those with low expression. MUC5B expression was lower in preterm-born adults with bronchial hyperreactivity and higher in those who reported having phlegm compared with those who did not have these signs. Conclusions: Unlike patients with asthma, preterm-born adults with or without BPD do not exhibit increased MUC5AC expression compared with healthy controls. However, the associations of MUC5AC and MUC5B expression with lung function, symptoms and quality-of-life indices suggest a potential clinical role for these mucins in this population.

  • Long-term neurodevelopmental outcomes in extremely preterm infants born at 22–26 weeks gestation: a follow-up of 2–2.5 years across two Swedish national cohorts from 2004–2007 to 2014–2016

    by Ulrika Ådén, Aijaz Farooqi, Lena Hellstrom-Westas, Karin Sävman, Thomas Abrahamsson, Lars J Björklund, Magnus Domellöf, Anders Elfvin, Fredrik Ingemansson, Fredrik Serenius, et al.

    Objective To compare neurodevelopmental outcomes in extremely preterm (EPT) children born across two epochs in Sweden. Design and setting Nationwide population-based cohorts of infants born at 22–26 weeks’ gestation in 2004–2007 (Cohort 1) and 2014–2016 (Cohort 2), comprising 1606 live births. Survivors were assessed at 2–2.5 years’ corrected age using the same protocol design. Main outcome The primary outcome was neurodevelopmental impairment (NDI), defined as a composite of moderate–severe cerebral palsy (CP), visual or hearing deficits, or moderate–severe cognitive, language or motor impairment assessed with the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley III). For children not assessed with Bayley-III, NDI was defined as moderate–severe speech delay, general developmental delay or categories of CP, vision and hearing impairment. Outcomes were compared using logistic regression to evaluate differences between cohorts and perinatal and socioeconomic risk factors. Results Of 1188 eligible survivors, 1062 (89.3%) were assessed (mean gestational age (GA) 24.8 weeks; 54.9% male). The prevalence of moderate–severe NDI at 22, 23, 24, 25 and 26 weeks’ gestation was 60% vs 52%, 51% vs 51%, 34% vs 42%, 27% vs 32% and 17% vs 24% in Cohorts 1 and 2, respectively. Overall prevalence did not differ significantly (27% vs 35%; adjusted OR (AOR) 1.2, 95% CI 0.94 to 1.6). Among 724 (68%) children assessed with Bayley III, Cohort 2 had higher rates of cognitive delay (21.6% vs 11.3%; AOR 1.8, 95% CI 1.1 to 3.4) and language delay (40.9% vs 16.1%; AOR 3.3, 95% CI 1.4 to 4.1). Low GA and maternal country of birth outside the Nordic region were the strongest predictors of NDI and cognitive delay, the latter association confined to Cohort 2. Conclusion Although survival of EPT infants in Sweden has improved, long-term neurodevelopmental outcomes have not. The root causes of failed improvements in long-term outcomes for EPT infants are complex and need further clarification.


  • Open Access

    Respiratory support and bronchopulmonary dysplasia in infants born at 22–26 weeks gestation in Sweden, 2004–2007 and 2014–2016

    by Linn Löfberg, Thomas Abrahamsson, Lars J. Björklund, Lena Hellström Westas, Aijaz Farooqi, Magnus Domellöf, Ulrika Ådén, Christian Gadsbøll, Karin Källén, David Ley, et al.

    Background: Our aim was to evaluate if increased survival and new ventilation strategies were accompanied by a changed incidence of bronchopulmonary dysplasia (BPD) in Sweden over a decade.Methods: Data from two Swedish population-based studies of live-born infants with gestational age (GA) 22–26 weeks, born during 2004–2007 (n=702) and 2014–2016 (n=885), were compared for survival, any BPD, moderate BPD and severe BPD and the composite outcomes of any BPD or death and severe BPD or death at 36 weeks postmenstrual age (PMA). Ventilation strategies and interventions were analysed. Any BPD was defined as the use of supplemental oxygen or any respiratory support at 36 weeks PMA, moderate BPD as nasal cannula with versus68%. Moderate BPD increased from 37% to 47% (p=0.003), while the incidence of severe BPD decreased from 28% to 23% (pversus75%.Conclusion: Even though an increased survival of infants born at 22–26 weeks GA was accompanied by an increased duration of invasive and non-invasive respiratory support, the incidence of any BPD remained unchanged, while severe BPD decreased in infants alive at 36 weeks PMA.


  • Open Access

    Centralisation of extremely preterm births and decreased early postnatal mortality in Sweden, 2004‐2007 versus 2014‐2016

    by Christian Gadsbøll, Lars J. Björklund, Mikael Norman, Thomas Abrahamsson, Magnus Domellöf, Anders Elfvin, Aijaz Farooqi, Lena Hellström‐Westas, Stellan Håkansson, Karin Källén, et al.

    Aim: We evaluated the increased centralisation of extremely preterm (EPT) births in Sweden in relation to the changes in mortality and morbidity.Methods: Population‐based data covering Swedish live births from 22 + 0 to 26 + 6 weeks of gestation during 2004–2007 and 2014–2016 were analysed for associations between time‐period, birth within (inborn) or outside (outborn) regional centres, and outcomes.Results: Among 1626 liveborn infants, 703 were born in 2004–2007 and 923 in 2014–2016. Birth outside (vs. within) regional centres was associated with a higher infant mortality even after adjustment for birth cohort, gestational age, birthweight standard deviation score and infant sex (adjusted odds ratio 2.01, 95% confidence interval 1.31–3.07, p = 0.001). The higher 1‐year mortality in outborn infants was mainly due to more deaths within 24 h after birth. Outborn infants had a higher incidence of intraventricular haemorrhage grade 3–4 than inborn infants (22% vs. 14% in 2004–2007, and 22% vs. 13% in 2014–2016, both p < 0.05). While survival to 1 year without major morbidity increased in inborn infants (33%–40%, p = 0.008), it remained unchanged in outborn infants (29% vs. 30%, p = 0.88).Conclusion: Centralisation of EPT births contributed to a lower 1‐year mortality in 2014–2016 than that in 2004–2007, attributed to a decrease in deaths before 24 h among inborn infants.


  • Open Access

    Lung function in young adulthood in relation to moderate-to-late preterm birth

    by Björn Lundberg, Simon Kebede Merid, Petra Um-Bergström, Gang Wang, Anna Bergström, Sandra Ekström, Inger Kull, Erik Melén, Jenny Hallberg

    Background: Moderate-to-late preterm birth (32 to 1) at 24 years of age (−0.28 z-score, p=0.045), compared to males born term. In females, no difference was seen at 24 years, partly explained by a significant catch up in FEV1between 16 and 24 years (0.18 z-score, p=0.01). Lung function phenotypes described as “asthma-like”, “dysanapsis-like” and “preterm reference” were identified within the preterm group. Maternal overweight in early pregnancy was associated with “asthma-like” group membership (OR 3.59, p=0.02).Conclusion: Our results show impaired FEV1at peak lung function in males born moderate-to-late preterm, while females born moderate-to-late preterm had significant catch up between the ages of 16 and 24 years. Several phenotypes of lung function impairment exist in individuals born moderate-to-late preterm.


  • Open Access

    Factors associated with the increased incidence of necrotising enterocolitis in extremely preterm infants in Sweden between two population-based national cohorts (2004–2007 vs 2014–2016)

    by Pontus Challis, Karin Källén, Lars Björklund, Anders Elfvin, Aijaz Farooqi, Stellan Håkansson, David Ley, Mikael Norman, Erik Normann, Fredrik Serenius, et al.

    Objective To investigate potential risk factors behind the increased incidence of necrotising enterocolitis (NEC) in Swedish extremely preterm infants. Design Registry data from two population-based national cohorts were studied. NEC diagnoses (Bell stage ≥II) were validated against hospital records. Patients All liveborn infants 7 days) (HR=2.7 (95% CI 1.5 to 5.0), p=0.001). In propensity score analysis, a significant epoch difference in NEC incidence (12% vs 2.8%, pConclusions The increase in NEC incidence between epochs was limited to cases occurring after 7 days of life and was partly explained by increased survival in the most extremely preterm infants. Misclassification of NEC is common.


  • One-year survival and outcomes of infants born at 22 and 23 weeks of gestation in Sweden 2004–2007, 2014–2016 and 2017–2019

    by Aijaz Farooqi, Stellan Hakansson, Fredrik Serenius, Karin Kallen, Lars Björklund, Erik Normann, Magnus Domellöf, Ulrika Ådén, Thomas Abrahamsson, Anders Elfvin, et al.

    Objective To explore associations between perinatal activity and survival in infants born at 22 and 23 weeks of gestation in Sweden. Design/Setting Data on all births at 22 and 23 weeks’ gestational age (GA) were prospectively collected in 2004–2007 (T1) or obtained from national registers in 2014–2016 (T2) and 2017–2019 (T3). Infants were assigned perinatal activity scores based on 3 key obstetric and 4 neonatal interventions. Main outcome One-year survival and survival without major neonatal morbidities (MNM): intraventricular haemorrhage grade 3–4, cystic periventricular leucomalacia, surgical necrotising enterocolitis, retinopathy of prematurity stage 3–5 or severe bronchopulmonary dysplasia. The association of GA-specific perinatal activity score and 1-year survival was also determined. Results 977 infants (567 live births and 410 stillbirths) were included: 323 born in T1, 347 in T2 and 307 in T3. Among live-born infants, survival at 22 weeks was 5/49 (10%) in T1 and rose significantly to 29/74 (39%) in T2 and 31/80 (39%) in T3. Survival was not significantly different between epochs at 23 weeks (53%, 61% and 67%). Among survivors, the proportions without MNM in T1, T2 and T3 were 20%, 17% and 19% for 22 weeks and 17%, 25% and 25% for 23 weeks’ infants (p>0.05 for all comparisons). Each 5-point increment in GA-specific perinatal activity score increased the odds for survival in first 12 hours of life (adjusted OR (aOR) 1.4; 95% CI 1.3 to 1.6) in addition to 1-year survival (aOR 1.2; 95% CI 1.1 to 1.3), and among live-born infants it was associated with increased survival without MNM (aOR 1.3; 95% CI 1.1 to 1.4). Conclusion Increased perinatal activity was associated with reduced mortality and increased chances of survival without MNM in infants born at 22 and 23 weeks of GA.


  • Open Access

    Increased cytotoxic T-cells in the airways of adults with former bronchopulmonary dysplasia

    by Petra Um-Bergström, Melvin Pourbazargan, Bettina Brundin, Marika Ström, Monika Ezerskyte, Jing Gao, Eva Berggren Broström, Erik Melén, Åsa M. Wheelock, Anders Lindén, et al.

    Rationale: Bronchopulmonary dysplasia (BPD) in preterm-born infants is a risk factor for chronic airway obstruction in adulthood. Cytotoxic T-cells are implicated in COPD, but their involvement in BPD is not known. Objectives: To characterise the distribution of airway T-cell subsets in adults with a history of BPD. Methods: Young adults with former BPD (n=22; median age 19.6 years), age-matched adults born preterm (n=22), patients with allergic asthma born at term (n=22) and healthy control subjects born at term (n=24) underwent bronchoalveolar lavage (BAL). T-cell subsets in BAL were analysed using flow cytometry. Results: The total number of cells and the differential cell counts in BAL were similar among the study groups. The percentage of CD3 + CD8 + T-cells was higher (p=0.005) and the proportion of CD3 + CD4 + T-cells was reduced (p=0.01) in the BPD group, resulting in a lower CD4/CD8 ratio (p=0.007) compared to the healthy controls (median 2.2 versus 5.3). In BPD and preterm-born study subjects, both CD3 + CD4 + T-cells (r s =0.38, p=0.03) and CD4/CD8 ratio (r s =0.44, p=0.01) correlated positively with forced expiratory volume in 1 s (FEV 1 ). Furthermore, CD3 + CD8 + T-cells were negatively correlated with both FEV 1 and FEV 1 /forced vital capacity (r s = −0.44, p=0.09 and r s = −0.41, p=0.01, respectively). Conclusions: Young adults with former BPD have a T-cell subset pattern in the airways resembling features of COPD. Our findings are compatible with the hypothesis that CD3 + CD8 + T-cells are involved in mechanisms behind chronic airway obstruction in these patients.


  • Open Access

    Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE

    by Gang Wang, Jenny Hallberg, Petra Um Bergström, Christer Janson, Göran Pershagen, Olena Gruzieva, Marianne van Hage, Antonios Georgelis, Anna Bergström, Inger Kull, et al.

    Background: Chronic bronchitis is associated with substantial morbidity among elderly adults, but little is known about its prevalence and risk factors in young adults. Our aim was to assess the prevalence and early-life risk factors for chronic bronchitis in young adults. Methods: Questionnaire data and clinical measures from the 24-year follow-up of the Swedish BAMSE (Child (Barn), Allergy, Milieu, Stockholm, Epidemiological) cohort were used. We assessed chronic bronchitis (CB) as the combination of cough and mucus production in the morning during winter. Environmental and clinical data from birth and onwards were used for analyses of risk factors. Results: At the 24-year follow-up, 75% (n=3064) participants completed the questionnaire and 2030 performed spirometry. The overall prevalence of CB was 5.5% (n=158) with similar estimates in males and females. 49% of CB cases experienced more than three self-reported respiratory infections in the past year compared to 18% in non-CB subjects (pversus 19% of non-CB cases). Statistically significant lower post-bronchodilator forced expiratory volume in 1 s/forced vital capacity were observed in CB compared to non-CB subjects (mean z-score −0.06 versus 0.13, p=0.027). Daily smoking (adjusted (a)OR 3.85, p−3 increase, p=0.009) and exclusive breastfeeding for ≤4 months (aOR 0.66, p=0.044) were associated with CB. Conclusion: Chronic bronchitis in young adults is associated with recurrent respiratory infections. Besides smoking, our results support the role of early-life exposures, such as air pollution and exclusive breastfeeding, for respiratory health later in life.